Peroxiredoxin I and II in Human Eyes: Cellular Distribution and Association with Pterygium and DNA Damage

Journal of Histochemistry and Cytochemistry

Volumn 62, Issue 1, 2014, Pages 85-96

  Klebe, Sonja ^a   Callahan, Thomas ^a   Power, John H T ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

8 hydroxy 2' deoxyguanosine antibody; ciliary body; confocal microscopy; cornea; immunohistochemistry; iris; lens; mitochondria; retina; western blotting

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; 8 HYDROXYDEOXYGUANOSINE; DNA; MITOCHONDRIAL DNA; PEROXIREDOXIN 1; PEROXIREDOXIN 2;

ARTICLE; BASAL CELL; CELL LABELING; CELLULAR DISTRIBUTION; CILIARY BODY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; CORNEA LIMBUS; CYTOPLASM; DNA DAMAGE; EPITHELIUM CELL; EYE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRIS; LENS; MELANOCYTE; OXIDATION; OXIDATIVE STRESS; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PTERYGIUM; SCLERA; ULTRAVIOLET RADIATION; WESTERN BLOTTING;

EID: 84891094556     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155413508409     Document Type: Article

References (40)

1. Behndig A,Svensson B,Marklund S,Karlsson K.Superoxide dismutase isoenzymes in the human eye.Invest Ophthalmol Vis Sci. 1998;39:471-475.
2. Black AT,Gray JP,Shakarjian MP,Laskin DL,Heck DE,Laskin JD.Distinct effects of ultraviolet B light on antioxidant expression in undifferentiated and differentiated mouse keratinocytes.Carcinogenesis. 2008;29:219-225.
3. Chalkia AK,Spandidos DA,Detorakis ET.Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review).Int J Mol Med. 2013;32:539-543.
4. Cimpean AM,Sava MP,Raica M.DNA damage in human pterygium: One-shot multiple targets.Mol Vis. 2013;19:348-356.
5. Chamberlain CG,Mansfield KJ,Cerra A.Glutathione and catalase suppress TGFbeta-induced cataract-related changes in cultured rat lenses and lens epithelial explants.Mol Vis. 2009;15:895-905.
6. Chui J,Coroneo MT,Tat LT,Crouch R,Wakefield D,Di Girolamo N.Ophthalmic pterygium: a stem cell disorder with premalignant features.Am J Pathol. 2011;178:817-827.
7. Crouch RK,Goletz P,Snyder A,Coles WH.Antioxidant enzymes in human tears.J Ocul Pharmacol. 1991;7:253-258.
8. Fatma N,Kubo E,Sen M,Agarwal N,Thoreson WB,Camras CB,Singh DP.Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.Brain Res. 2008;1233:63-78.
9. Fox T,Gotlinger KH,Dunn MW,Lee OL,Milman T,Zaidman G,Schwartzman ML,Bellner L.Dysregulated heme oxygenase-ferritin system in pterygium pathogenesis.Cornea. 2013;32:1276-1282.
10. Furuta J,Nobeyama Y,Umebayashi Y,Otsuka F,Kikuchi K,Ushijima T.Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.Cancer Res. 2006;66:6080-6086.
11. Hasanova N,Kubo E,Kumamoto Y,Takamura Y,Akagi Y.Age-related cataracts and Prdx6: correlation between severity of lens opacity, age and the level of Prdx 6 expression.Br J Ophthalmol. 2009;93:1081-1084.
12. Jurkunas UV,Rawe I,Bitar MS,Zhu C,Harris DL,Colby K,Joyce NC.Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy.Invest Ophthalmol Vis Sci. 2008;49:2956-2963.
13. Kau HC,Tsai CC,Lee CF,Kao SC,Hsu WM,Liu JH,Wei YH.Increased oxidative DNA damage, 8-hydroxydeoxy-guanosine, in human pterygium.Eye. 2006;20:826-831.
14. Kubo E,Fatma N,Akagi Y,Beier DR,Singh SP,Singh DP.TAT-mediated PRDX6 protein transduction protects against eye lens epithelial cell death and delays lens opacity.Am J Physiol. 2008;294:C842-C855.
15. Lee GA,Hirst LW,Sheehan M.Knowledge of sunlight effects on the eyes and protective behaviours in the general community.Ophthalmic Epidemiol. 1994;1:67-84.
16. Lee TH,Kim SU,Yu SL,Kim SH,Park DS,Moon HB,Dho SH,Kwon KS,Kwon HJ,Han YH,Jeong S,Kang SW,Shin HS,Lee KK,Rhee SG,Yu DY.Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice.Blood. 2003;101:5033-5038.
17. Lee W,Choi KS,Riddell J,Ip C,Ghosh D,Park JH,Park YM.Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2.J Biol Chem. 2007;282:22011-22022.
18. Lin D,Barnett M,Grauer L,Robben J,Jewell A,Takemoto L,Takemoto DJ.Expression of superoxide dismutase in whole lens prevents cataract formation.Mol Vis. 2005;11:853-858.
19. Maxia C,Perra MT,Demurtas P,Minerba L,Murtas D,Piras F,Corbu A,Gotuzzo DC,Cabrera RG,Ribatti D,Sirigu P.Expression of survivin in pterygium and relationship with oxidative DNA damage.J Cell Mol Med. 2008;12:2372-2380.
20. Moran DJ,Hollows FC.Pterygium and ultraviolet radiation: a positive correlation.Br J Ophthalmol. 1984;68:343-346.
21. Moreira EF,Kantorow M,Rodriguez IR.Peroxiredoxin 3 (PDRX3) is highly expressed in the primate retina especially in blue cones.Exp Eye Res. 2008;86:452-455.
22. Neumann CA,Krause DS,Carman CV,Das S,Dubey DP,Abraham JL,Bronson RT,Fujiwara Y,Orkin SH,Van Etten RA.Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression.Nature. 2003;424:561-565.
23. Pak JH,Choi HJ,Choi CY,Tchah H.Expression of 1-cys peroxiredoxin in the corneal wound-healing process.Cornea. 2006;25:S29-S35.
24. Peng ML,Tsai YY,Chiang CC,Huang YC,Chou MC,Yeh KT,Lee H,Cheng YW.CYP1A1 protein activity is associated with allelic variation in pterygium tissues and cells.Mol Vis. 2012;18:1937-1943.
25. Perra MT,Maxia C,Corbu A,Minerba L,Demurtas P,Colombari R,Murtas D,Bravo S,Piras F,Sirigu P.Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.Mol Vis. 2006;12:1136-1142.
26. Power JHT,Asad S,Chataway T,Chegini F,Manavis J,Temlett JA,Jensen PH,Blumbergs PC,Gai W.Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and associations with Alzheimer's disease pathology.Acta Neuropath. 2008;115:611-622.
27. Power JHT,Blumbergs PC.Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies.Acta Neuropath. 2009;117:63-73.
28. Shoham A,Hadziahmetovic M,Dunaief JL,Mydlarski MB,Schipper HM.Oxidative stress in diseases of the human cornea.Free Radic Biol Med. 2008;45:1047-1055.
29. Siak JJ,Ng SL,Seet LF,Beuerman RW,Tong L.The nuclear-factor kappaB pathway is activated in pterygium.Invest Ophthalmol Vis Sci. 2011;52:230-236.
30. Tchah H,Kim MJ,Kim TI,Choi HJ,Kim JY,Kim MJ,Pak JH.Regulation of 1-cys peroxiredoxin expression in the process of stromal wound healing after photorefractive keratectomy.Invest Ophthalmol Vis Sci. 2005;46:2396-2403.
31. Tsai YY,Cheng YW,Lee H,Tsai FJ,Tseng SH,Lin CL,Chang KC.Oxidative DNA damage in pterygium.Mol Vis. 2005;11:71-75.
32. Ucakhan OO,Kanpolat A,Elgun S,Durak I.The role of oxidative mechanisms in the etiopathogenesis of pterygium: a preliminary study.Opthalmologica. 2009;223:41-46.
33. Usui S,Oveson BC,Lee SY,Jo YJ,Yoshida T,Miki A,Miki K,Iwase T,Lu L,Campochiaro PA.NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa.J Neurochem. 2009;110:1028-1037.
34. Wang Z,Handa JT,Green WR,Stark WJ,Weinberg RS,Jun AS.Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.Ophthalmology. 2007;114:1453-1460.
35. Weinstein O,Rosenthal G,Zirkin H,Monos T,Lifshitz,Argov S.Overexpression of p53 suppressor gene in pterygia.Eye. 2002;16:619-621.
36. Wlodarczyk J,Whyte P,Cockrum P,Taylor H.Pterygium in Australia: a cost of illness study.Clin Exp Ophthalmol. 2001;29:370-375.
37. Wollensak G,Redl B.Gel electrophoretic analysis of corneal collagen after photodynamic cross-linking treatment.Cornea. 2008;27:353-356.
38. Wood ZA,Schroder E,Harris JR.Poole LB Structure, mechanism and regulation of peroxiredoxins.Trend Biochem Sci. 2003;28:32-40.
39. Zamora DO,Riviere M,Choi D,Pan Y,Planck SR,Rosenbaum JT,David LL,Smith JR.Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.Mol Vis. 2007;13:2058-2065.
40. Zhang J,Perry G,Smith MA,Robertson D,Olson SJ,Graham DG,Montine TJ.Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.Am J Path. 1999;154:1423-1429.